Armodafinil is an enantiopure eugeroic agent belonging to the sulfinylacetamide class, clinically indicated for the treatment of excessive daytime sleepiness associated with obstructive sleep apnea, narcolepsy,… Read more
Armodafinil is an enantiopure eugeroic agent belonging to the sulfinylacetamide class, clinically indicated for the treatment of excessive daytime sleepiness associated with obstructive sleep apnea, narcolepsy, and shift work disorder. Accurate analytical evaluation of this medication requires high-quality Armodafinil reference standards alongside a comprehensive profile of its related compounds. This selection includes key impurities, such as 2-[(Diphenylmethyl)thio]acetic acid, as well as essential metabolites like thiobenzhydrol and chiral intermediates like benzhydryl carbamimidothioate. Pharmaceutical laboratories utilize these materials to support critical activities, including impurity profiling, method validation, and rigorous quality control testing. By incorporating these related reference materials into analytical workflows, researchers ensure the reliable identification and quantification of potential degradants, confirming both the efficacy and safety of the final pharmaceutical formulation.